Synthaverse

Update in progress

SVE.WA (Warsaw)

Synthaverse S.A. is a Polish pharmaceutical company that develops and sells medicines, medical devices, and laboratory reagents in Poland, the EU and beyond. It operates in two segments—BCG and Traditional—and offers OnkoBCG 50/100 for bladder cancer, GAMMA anty-D 50/150, GAMMA anty HBs 200, BCG 10, Distreptaza, LAKCID probiotic, pseudocholinesterase, and other reagents. It also provides contract manufacturing of injectables, lyophilisates, biologics and suppositories. Formerly BIOMED-LUBLIN, renamed in 2023; founded 1944, based in Lublin.